The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs adjuvant chemotherapy alone for localized soft tissue sarcoma (NACLESS, JCOG2102).
 
Yuki Funauchi
No Relationships to Disclose
 
Satoshi Tsukushi
No Relationships to Disclose
 
Hiroaki Hiraga
No Relationships to Disclose
 
Akio Sakamoto
No Relationships to Disclose
 
Toshiyuki Kunisada
No Relationships to Disclose
 
Akihito Nagano
No Relationships to Disclose
 
Koji Hiraoka
Honoraria - Daiichi-Sankyo, Asahikasei, Hisamitsu
 
Kazutaka Kikuta
No Relationships to Disclose
 
Tsukasa Yonemoto
No Relationships to Disclose
 
Keisuke Ae
No Relationships to Disclose
 
Akira Kawai
Honoraria - Boehringer Ingelheim; Taiho Pharmaceutical
 
Tetsuya Sekita
No Relationships to Disclose
 
Ryunosuke Machida
No Relationships to Disclose
 
Yuta Sekino
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; CMIC Co., Ltd.; Kyowa Kirin Co., Ltd.; m3.com
 
Yoshinao Oda
No Relationships to Disclose
 
Toshifumi Ozaki
No Relationships to Disclose
 
Kazuhiro Tanaka
Honoraria - Bayer; Eisai; Hisamitsu Pharmaceutical; Taiho Pharmaceutical